By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 233
NEW YORK (Reuters Health) – Both obesity and type 2 diabetes, owing to their harmful effects on adipocytokines and inflammatory mediators, contribute to increased breast cancer risk in…
NEW YORK (Reuters Health) – New research from France indicates that patients using anti-tumor necrosis factor (TNF) monoclonal antibody therapy are at greater risk for developing tuberculosis than…
NEW YORK (Reuters Health) – Celiac disease is 4 times more common now than it was in the 1950’s, according to researchers at the Mayo Clinic in Rochester,…
NEW YORK (Reuters Health) – Obesity is a strong risk factor for loss of residual kidney function after initiation of dialysis, according to new data from the prospective…
NEW YORK (Reuters Health) – Serial measurement of blood urea nitrogen (BUN) provides the most valuable prognostic information of six routinely collected admission laboratory tests in patients admitted…
NEW YORK (Reuters Health) – As plasma levels of adiponectin, a protein produced by fat cells, rise, the risk of type 2 diabetes decreases, according to the results…
NEW YORK (Reuters Health) – Patients who undergo bariatric surgery should not expect it to cure their obstructive sleep apnea, according to results of a meta-analysis published in…
NEW YORK (Reuters Health) – Treatment of cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) by loop electrosurgical excision (LEEP) may lead to a reduction in acquisition of…
NEW YORK (Reuters Health) – In a prospective, randomized trial, a single daily tablet containing efavirenz, emtricitabine, and tenofovir (Atripla; Bristol Myers Squibb & Gilead Sciences LLC) maintained…
NEW YORK (Reuters Health) – Overweight patients with type 2 diabetes who follow either a low-carbohydrate diet or a low-fat diet have similar outcomes after one year in…
